Add to Favorites Newsroom RSS Share
fb-shareMemorial Sloan Kettering Cancer Center
New York, NY USA

Our News on Newswise

Cracking a Code: Landmark Prospective Study Helps Researchers Better Understand Which MGUS Patients Will Progress to a Multiple Myeloma Diagnosis

Memorial Sloan Kettering Cancer Center (MSK) researchers published new results that found that individuals with low-risk or intermediate-risk myeloma precursor disease known as monoclonal gammopathy of undetermined significance (MGUS) can convert to...
18-Jul-2019 11:05 AM EDT Add to Favorites

MSK-ACCESS Receives New York State Approval for New Molecular Assay

Memorial Sloan Kettering Cancer Center (MSK) announced that the New York State Department of Health has issued an approval for a new molecular assay called Analysis of Circulating cfDNA to Evaluate Somatic Status (MSK-ACCESS).
21-Jun-2019 3:00 PM EDT Add to Favorites

Following Milestone FDA Approval, MSK Researchers Address Resistance to Larotrectinib through Next-Generation TRK-Targeted Therapeutic

LOXO-195, a next-generation TRK inhibitor also known as BAY 2731954, has shown signs of clinical activity in individuals with NTRK gene fusion-positive solid tumors that have become resistant to first-generation TRK inhibitors. Results from a phase...
1-Apr-2019 4:05 PM EDT Add to Favorites

MSK Researchers Identify a New Method to “Genetically Cloak” Cancer-Fighting Immune Cells

During cancer immunotherapy, immune cells often undergo a form of cellular suicide, termed apoptosis, which can limit the therapy’s effectiveness.
29-Jan-2019 12:05 PM EST Add to Favorites

New Study Reveals Gut Microbes May Help Protect People Having a Bone Marrow Transplant

Researchers at Memorial Sloan Kettering Cancer Center (MSK) reported results from a new study that looks at the likelihood of complications for people undergoing bone marrow transplants (BMTs). The observational study found that people with lower...
3-Dec-2018 10:05 AM EST Add to Favorites

Memorial Sloan Kettering Researchers at ASH Annual Meeting

MSK experts in CAR-T therapy, immunotherapy, leukemia, lymphoma, blood and marrow stem cell transplantation, and more, are also available to comment on meeting news.
29-Nov-2018 3:05 PM EST Add to Favorites

Fecal Transplants Proven to Restore Health-Promoting Bacteria

A randomized clinical trial at Memorial Sloan Kettering Cancer Center (MSK) has shown that fecal microbiota transplants (FMTs)
8-Oct-2018 3:55 PM EDT Add to Favorites

Memorial Sloan Kettering Researchers Build a New Model of Genetically Engineered Immune Cells That May Combat Solid Tumors in the Future

Scientists at Memorial Sloan Kettering Cancer Center (MSK) announced that they have built a new model of genetically engineered immune cells in mice that may allow them to fight solid tumors.
14-Aug-2018 12:05 PM EDT Add to Favorites

see all news

Our YouTube Videos


Memorial Sloan Kettering Cancer Center (MSK) is the world’s oldest and largest private institution devoted to prevention, patient care, research, and education in cancer. Our scientists and clinicians generate innovative approaches to better understand, diagnose, and treat cancer. Our specialists are leaders in biomedical research and in translating the latest research to advance the standard of cancer care worldwide.


Jeannine Briceno
Media/Project Coordinator

Jeanne D'Agostino
Director of Media, Public Relations


Christine Hickey
Vice President, Strategic Communications & Public


Caitlin Hool
Senior Media Associate
cancer medicine


Nicole McNamara
Senior Media Associate


Avice Meehan
SVP Communications and Public Affairs

Courtney Nowak
Senior Media Associate
MSK Regional Locations, MSK Cancer Alliance


Emily ODonnell
Senior Communications Assoc.

Rebecca Williams
Media Strategist


Twitter twitter-icon

Chat now!